Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
- PMID: 33579427
- PMCID: PMC8800451
- DOI: 10.1016/bs.acr.2020.10.005
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
Abstract
Intrahepatic cholangiocarcinoma (iCCA) is a relatively rare, but highly lethal and biologically complex primary biliary epithelial cancer arising within liver. After hepatocellular carcinoma, iCCA is the second most common primary liver cancer, accounting for approximately 10-20% of all primary hepatic malignancies. Over the last 10-20 years, iCCA has become the focus of increasing concern largely due to its rising incidence and high mortality rates in various parts of the world, including the United States. The challenges posed by iCCA are daunting and despite recent progress in the standard of care and management options for iCCA, the prognosis for this cancer continues to be dismal. In an effort to provide a framework for advancing our understanding of iCCA malignant aggressiveness and therapy resistance, this review will highlight key etiological, biological, molecular, and microenvironmental factors hindering more effective management of this hepatobiliary cancer. Particular focus will be on critically reviewing the cell origins and morpho-molecular heterogeneity of iCCAs, providing mechanistic insights into high risk fibroinflammatory cholangiopathies associated with iCCA development, and notably discussing the deleterious role played by the tumor reactive desmoplastic stroma in regulating iCCA malignant progression, lymphangiogenesis, and tumor immunobiology.
Keywords: Cancer-associated fibroblasts; Extracellular matrix; Fibroinflammatory risk conditions; Immune milieu; M2 macrophages; Morpho-molecular classification; Periostin; Therapeutic targeting; Transforming growth factor-β; Tumor reactive microenvironment.
© 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement The authors (A.E.S., M.S., and M.C.) have no financial or personal disclosures relevant to this manuscript.
Figures


References
-
- Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, & Sidransky D (2000). p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. Journal of Hepato-Biliary-Pancreatic Surgery, 7: 426–431. - PubMed
-
- Aishima S, Taguchi K, Sugimachi K, Asayama Y, Nishi H, Shimada M, et al. (2002). The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma. International Journal of Surgical Pathology, 10: 47–56. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical